Application no. and date | 08831500.7 (espacenet) (Federated) (European Patent Register), 20080919 | Patent/reg. no. and date | DK/EP 2200610, 20180110 | Publication date | 20100630 | Priority no. and date | US 974426 P, 20070921, US 986250 P, 20071107, US 50976, 20080506 | EP pub. no. and date |
EP 2200610 20100630 | Effective date | | Applicant/owner | Acadia Pharmaceuticals Inc., 3611 Valley Centre Drive San Diego CA 92130 California , US | Applicant ref. no. | ACA ACADIA.127VEP | Inventor | HACKSELL, Uli, 3507 Bayshore Blvd, Ph 2301
Tampa, FL 33639, US, MCFARLAND, Krista, 2608 Cherry Lane
Walnut Creek, CA 94597, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/4468 (2006.01) , A61P 25/00 (2006.01) | Title | ADMINISTRATION AF PIMAVANSERIN SAMMEN MED ANDRE MIDLER | Int. application no. | US2008077139 | Int. publication no. | WO2009039460 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|